Global Metabolomics Market by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
Metabolomics can be defined as the study of metabolites or low molecular weight molecules found inside the cells and the biological systems. This branch of science basically aims at the comparison finding out the differences between biological samples and is based on their metabolite profile. Metabolomics generally makes the use of analytical process like Chromatography, spectroscopy and multi variable analysis.
The market of metabolomics is expected to increase in forecasted period due to increasing adoption of the technology to various fields such as toxicology, nutrigenomics, and Functional genomics. North America is having the largest share of market, Europe and Asia pacific follow It respectively.
The major driving factors of the market are the continuous research and development made in the field also the funding allotted by various government of different geographic regions, Risisng popularity of personalized medicine and and development in metabolite profiling is also contributing to its growth. It has got its application in several other lucrative industries such as agriculture, Biomaker discovery etc. Some of the challenges in the field are its complexity in holding and interpreting large amount of data, unavailability of complete metabolite libraries and lack of standardized people also adds to the challenges of the field.
The market of metabolomics is segmented on the basis of techniques used, and the various fields of application. Geographically the market is segmented into North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, RoE), Asia-Pacific (India, Japan, Australia, China, Korea, RoAPAC) and Rest of World (Latin America, MENA and Africa). The key providers of metabolomics in the market include: Agilent technologies, Waters Corporation, Big medicine INC, Biocrates Life Sciences etc.
Companies Profiled include
1. Agilent technologies
2. Big medicine INC.
3. Biocrates Life Sciences
4. Bio-Rad laboratories
5. Bruker Corporation
6. Chenomx
7. Danaher Corporation
8. Human Metabolomics Technologies, Inc.
9. LECO Corporation
10. Metabolon, Inc.
11. Shimadzu Corporation
12. Thermo Fisher Scientific Inc
13. Waters Corporation
14. Ingenuity systems
15. Metanomics heatlth
16. Molecular biometrics
17. Umetrics
18. Unilever
This Occams Research Report covers
1. Historical data
2.Revenue forecasts, growth rates and CAGR upto 2021
3.Industry Analysis
4.Competitive Analysis
5. Key geographic growth data
The market of metabolomics is expected to increase in forecasted period due to increasing adoption of the technology to various fields such as toxicology, nutrigenomics, and Functional genomics. North America is having the largest share of market, Europe and Asia pacific follow It respectively.
The major driving factors of the market are the continuous research and development made in the field also the funding allotted by various government of different geographic regions, Risisng popularity of personalized medicine and and development in metabolite profiling is also contributing to its growth. It has got its application in several other lucrative industries such as agriculture, Biomaker discovery etc. Some of the challenges in the field are its complexity in holding and interpreting large amount of data, unavailability of complete metabolite libraries and lack of standardized people also adds to the challenges of the field.
The market of metabolomics is segmented on the basis of techniques used, and the various fields of application. Geographically the market is segmented into North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, RoE), Asia-Pacific (India, Japan, Australia, China, Korea, RoAPAC) and Rest of World (Latin America, MENA and Africa). The key providers of metabolomics in the market include: Agilent technologies, Waters Corporation, Big medicine INC, Biocrates Life Sciences etc.
Companies Profiled include
1. Agilent technologies
2. Big medicine INC.
3. Biocrates Life Sciences
4. Bio-Rad laboratories
5. Bruker Corporation
6. Chenomx
7. Danaher Corporation
8. Human Metabolomics Technologies, Inc.
9. LECO Corporation
10. Metabolon, Inc.
11. Shimadzu Corporation
12. Thermo Fisher Scientific Inc
13. Waters Corporation
14. Ingenuity systems
15. Metanomics heatlth
16. Molecular biometrics
17. Umetrics
18. Unilever
This Occams Research Report covers
1. Historical data
2.Revenue forecasts, growth rates and CAGR upto 2021
3.Industry Analysis
4.Competitive Analysis
5. Key geographic growth data
1. INTRODUCTION
1.1 Executive Summary
1.2 Estimation methodology
2. MARKET OVERVIEW
2.1 Market definition and scope
2.2 Key findings
2.3 Parametric analysis
2.3.1 Funding to the field by government
2.3.2 R&D expenditure in the sector across geographies
2.3.3 Use in various sectors
2.4 Key market insights
2.4.1 Top 3 emerging countries
2.4.2 Top 3 revenue generating segments
2.4.3 Market trends
2.4.4 Winning strategy
2.4.5 Pipeline analysis
2.5 R & D Scenario
2.6 Competitive intelligence
2.6.1 Market share analysis
2.6.2 Top winning strategies
2.6.3 Case study; top competitive moves
2.7 Value chain analysis
2.8 Key buying criteria
2.9 Strategic recommendation
2.10 Strategic conclusion
3. MARKET DETERMINANTS
3.1 Market drivers
3.1.1 Research and development going in the field
3.1.2 Support of government
3.1.3 Rising popularity of personalized medicine
3.1.4 Use in sectors such as drug discovery and toxicology
3.2 Market Restraints
3.2.1 Low adoption rate
3.2.2 Data complexity
3.2.3 Shortage of skilled personal
3.3 Market opportunities
3.3.1 Proliferation of metabolomics laboratory management system
3.3.2 Developments in metabolite profiling
3.3.3 Biomarker discovery
3.4 Market challenges
3.4.1 unavailability of complete metabolite libraries
3.4.2 Lack of standardized protocols
4. SECTOR ANALYSES
4.1 Parent market analysis
4.2 Competitor market analysis
4.3 Alternative market analysis
5 MARKET SEGMENTATION
5.1 Global metabolomics market on the basis of techniques used, 2014-2021, ($ millions)
5.1.1 Global metabolomics market on the basis of Separation method, 2014-2021, ($ millions)
5.1.2 Global metabolomics market on the basis of Ionization method, 2014-2021, ($ millions)
5.1.3 Global metabolomics market on the basis of Detection method, 2014-2021, ($ millions)
5.1.4 Global metabolomics market on the basis of Statistical methods, 2014-2021, ($ millions)
5.2 Global metabolomics market on the basis of application, 2014-2021, ($ millions)
5.2.1 Global metabolomics market on the basis of use in agriculture, 2014-2021, ($ millions)
5.2.2 Global metabolomics market on the basis of use in Bio maker discover, 2014-2021, ($ millions)
5.2.3 Global metabolomics market on the basis of use in personalized medicine, 2014-2021, ($ millions)
5.2.4 Global metabolomics market on the basis of use in toxicology, 2014-2021, ($ millions)
5.2.5 Global metabolomics market on the basis of use in functional genomics, 2014-2021, ($ millions)
5.2.6 Global metabolomics market on the basis of use in Nutrigenomics, 2014-2021, ($ millions)
6. GEOGRAPHIC ANALYSIS
6.1 North America Metabolomics market, 2014-2021, ($ millions)
6.1.1 U.S Metabolomics market, 2014-2021, ($millions)
6.1.2 Canada Metabolomics market, 2014 -2021, ($millions)
6.2 Europe Metabolomics market, 2014 -2021, ($millions)
6.2.1 U.K Metabolomics market, 2014 -2021, ($millions)
6.2.2 Germany Metabolomics market, 2014 -2021, ($millions)
6.2.3 France Metabolomics market, 2014 -2021, ($millions)
6.1.1 Spain Metabolomics market, 2014 -2021, ($millions)
6.1.2 Italy Metabolomics market, 2014 -2021, ($millions)
6.1.3 others
6.2 Asia Pacific
6.2.1 China Metabolomics market, 2014 -2021, ($millions)
6.2.2 India Metabolomics market, 2014 -2021, ($millions)
6.2.3 Korea Metabolomics market, 2014 -2021, ($millions)
6.2.4 Japan Metabolomics market, 2014 -2021, ($millions)
6.2.5 Australia Metabolomics market, 2014 -2021, ($millions)
6.2.6 Rest of apac
6.3 Rest of the world
7. COMPANY PROFILING
7.1 Agilent technologies
7.2 Big medicine INC.
7.3 Biocrates Life Sciences
7.4 Bio-Rad laboratories
7.5 Bruker Corporation
7.6 Chenomx
7.7 Danaher Corporation
7.8 Human Metabolome Technologies, Inc.
7.9 LECO Corporation
7.10 Metabolon, Inc.
7.11 Shimadzu Corporation
7.12 Thermo Fisher Scientific Inc
7.13 OWL
7.14 Takara bio
7.15 Merck
7.16 Waters Corporation
7.17 Cinmet
7.18 Metasysx
7.19 Prometheus metabolomics ltd.
7.20 Ms-Omnics
7.21 Ingenuity systems
7.22 Metanomics heatlth
7.23 Molecular biometrics
7.24 Umetrics
7.25 Unilever
1.1 Executive Summary
1.2 Estimation methodology
2. MARKET OVERVIEW
2.1 Market definition and scope
2.2 Key findings
2.3 Parametric analysis
2.3.1 Funding to the field by government
2.3.2 R&D expenditure in the sector across geographies
2.3.3 Use in various sectors
2.4 Key market insights
2.4.1 Top 3 emerging countries
2.4.2 Top 3 revenue generating segments
2.4.3 Market trends
2.4.4 Winning strategy
2.4.5 Pipeline analysis
2.5 R & D Scenario
2.6 Competitive intelligence
2.6.1 Market share analysis
2.6.2 Top winning strategies
2.6.3 Case study; top competitive moves
2.7 Value chain analysis
2.8 Key buying criteria
2.9 Strategic recommendation
2.10 Strategic conclusion
3. MARKET DETERMINANTS
3.1 Market drivers
3.1.1 Research and development going in the field
3.1.2 Support of government
3.1.3 Rising popularity of personalized medicine
3.1.4 Use in sectors such as drug discovery and toxicology
3.2 Market Restraints
3.2.1 Low adoption rate
3.2.2 Data complexity
3.2.3 Shortage of skilled personal
3.3 Market opportunities
3.3.1 Proliferation of metabolomics laboratory management system
3.3.2 Developments in metabolite profiling
3.3.3 Biomarker discovery
3.4 Market challenges
3.4.1 unavailability of complete metabolite libraries
3.4.2 Lack of standardized protocols
4. SECTOR ANALYSES
4.1 Parent market analysis
4.2 Competitor market analysis
4.3 Alternative market analysis
5 MARKET SEGMENTATION
5.1 Global metabolomics market on the basis of techniques used, 2014-2021, ($ millions)
5.1.1 Global metabolomics market on the basis of Separation method, 2014-2021, ($ millions)
5.1.2 Global metabolomics market on the basis of Ionization method, 2014-2021, ($ millions)
5.1.3 Global metabolomics market on the basis of Detection method, 2014-2021, ($ millions)
5.1.4 Global metabolomics market on the basis of Statistical methods, 2014-2021, ($ millions)
5.2 Global metabolomics market on the basis of application, 2014-2021, ($ millions)
5.2.1 Global metabolomics market on the basis of use in agriculture, 2014-2021, ($ millions)
5.2.2 Global metabolomics market on the basis of use in Bio maker discover, 2014-2021, ($ millions)
5.2.3 Global metabolomics market on the basis of use in personalized medicine, 2014-2021, ($ millions)
5.2.4 Global metabolomics market on the basis of use in toxicology, 2014-2021, ($ millions)
5.2.5 Global metabolomics market on the basis of use in functional genomics, 2014-2021, ($ millions)
5.2.6 Global metabolomics market on the basis of use in Nutrigenomics, 2014-2021, ($ millions)
6. GEOGRAPHIC ANALYSIS
6.1 North America Metabolomics market, 2014-2021, ($ millions)
6.1.1 U.S Metabolomics market, 2014-2021, ($millions)
6.1.2 Canada Metabolomics market, 2014 -2021, ($millions)
6.2 Europe Metabolomics market, 2014 -2021, ($millions)
6.2.1 U.K Metabolomics market, 2014 -2021, ($millions)
6.2.2 Germany Metabolomics market, 2014 -2021, ($millions)
6.2.3 France Metabolomics market, 2014 -2021, ($millions)
6.1.1 Spain Metabolomics market, 2014 -2021, ($millions)
6.1.2 Italy Metabolomics market, 2014 -2021, ($millions)
6.1.3 others
6.2 Asia Pacific
6.2.1 China Metabolomics market, 2014 -2021, ($millions)
6.2.2 India Metabolomics market, 2014 -2021, ($millions)
6.2.3 Korea Metabolomics market, 2014 -2021, ($millions)
6.2.4 Japan Metabolomics market, 2014 -2021, ($millions)
6.2.5 Australia Metabolomics market, 2014 -2021, ($millions)
6.2.6 Rest of apac
6.3 Rest of the world
7. COMPANY PROFILING
7.1 Agilent technologies
7.2 Big medicine INC.
7.3 Biocrates Life Sciences
7.4 Bio-Rad laboratories
7.5 Bruker Corporation
7.6 Chenomx
7.7 Danaher Corporation
7.8 Human Metabolome Technologies, Inc.
7.9 LECO Corporation
7.10 Metabolon, Inc.
7.11 Shimadzu Corporation
7.12 Thermo Fisher Scientific Inc
7.13 OWL
7.14 Takara bio
7.15 Merck
7.16 Waters Corporation
7.17 Cinmet
7.18 Metasysx
7.19 Prometheus metabolomics ltd.
7.20 Ms-Omnics
7.21 Ingenuity systems
7.22 Metanomics heatlth
7.23 Molecular biometrics
7.24 Umetrics
7.25 Unilever
LIST OF TABLES
1. GLOBAL METABOLOMICS MARKET ON THE BASIS OF TECHNIQUES USED, 2014-2021, ($ MILLIONS)
2. GLOBAL METABOLOMICS MARKET ON THE BASIS OF TECHNIQUES USED BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
3. GLOBAL METABOLOMICS MARKET ON THE BASIS OF SEPARATION METHOD, 2014-2021, ($ MILLIONS)
4. GLOBAL METABOLOMICS MARKET ON THE BASIS OF IONIZATION METHOD BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
5. GLOBAL METABOLOMICS MARKET ON THE BASIS OF DETECTION METHOD BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
6. GLOBAL METABOLOMICS MARKET ON THE BASIS OF STATISTICAL METHODS BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
7. GLOBAL METABOLOMICS MARKET ON THE BASIS OF APPLICATION, 2014-2021, ($ MILLIONS)
8. GLOBAL METABOLOMICS MARKET ON THE BASIS OF APPLICATION BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
9. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN AGRICULTURE, BY GEOGRAPHY 2014-2021, ($ MILLIONS)
10. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN BIO MAKER DISCOVER, BY GEOGRAPHY 2014-2021, ($ MILLIONS)
11. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN PERSONALIZED MEDICINE BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
12. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN TOXICOLOGY BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
13. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN FUNCTIONAL GENOMICS BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
14. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN NUTRIGENOMICS, 2014-2021, ($ MILLIONS)
1. GLOBAL METABOLOMICS MARKET ON THE BASIS OF TECHNIQUES USED, 2014-2021, ($ MILLIONS)
2. GLOBAL METABOLOMICS MARKET ON THE BASIS OF TECHNIQUES USED BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
3. GLOBAL METABOLOMICS MARKET ON THE BASIS OF SEPARATION METHOD, 2014-2021, ($ MILLIONS)
4. GLOBAL METABOLOMICS MARKET ON THE BASIS OF IONIZATION METHOD BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
5. GLOBAL METABOLOMICS MARKET ON THE BASIS OF DETECTION METHOD BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
6. GLOBAL METABOLOMICS MARKET ON THE BASIS OF STATISTICAL METHODS BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
7. GLOBAL METABOLOMICS MARKET ON THE BASIS OF APPLICATION, 2014-2021, ($ MILLIONS)
8. GLOBAL METABOLOMICS MARKET ON THE BASIS OF APPLICATION BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
9. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN AGRICULTURE, BY GEOGRAPHY 2014-2021, ($ MILLIONS)
10. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN BIO MAKER DISCOVER, BY GEOGRAPHY 2014-2021, ($ MILLIONS)
11. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN PERSONALIZED MEDICINE BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
12. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN TOXICOLOGY BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
13. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN FUNCTIONAL GENOMICS BY GEOGRAPHY, 2014-2021, ($ MILLIONS)
14. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN NUTRIGENOMICS, 2014-2021, ($ MILLIONS)
LIST OF FIGURES
1. GLOBAL METABOLOMICS MARKET ON THE BASIS OF SEPARATION METHOD, 2014-2021, ($ MILLIONS)
2. GLOBAL METABOLOMICS MARKET ON THE BASIS OF IONIZATION METHOD, 2014-2021, ($ MILLIONS)
3. GLOBAL METABOLOMICS MARKET ON THE BASIS OF DETECTION METHOD, 2014-2021, ($ MILLIONS)
4. GLOBAL METABOLOMICS MARKET ON THE BASIS OF STATISTICAL METHODS, 2014-2021, ($ MILLIONS)
5. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN AGRICULTURE, 2014-2021, ($ MILLIONS)
6. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN BIO MAKER DISCOVER, 2014-2021, ($ MILLIONS)
7. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN PERSONALIZED MEDICINE, 2014-2021, ($ MILLIONS)
8. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN TOXICOLOGY, 2014-2021, ($ MILLIONS)
9. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN FUNCTIONAL GENOMICS, 2014-2021, ($ MILLIONS)
10. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN NUTRIGENOMICS, 2014-2021, ($ MILLIONS)
11. U.S METABOLOMICS MARKET, 2014-2021, ($MILLIONS)
12. CANADA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
13. U.K METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
14. GERMANY METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
15. FRANCE METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
16. SPAIN METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
17. ITALY METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
18. CHINA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
19. INDIA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
20. KOREA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
21. JAPAN METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
22. AUSTRALIA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS
1. GLOBAL METABOLOMICS MARKET ON THE BASIS OF SEPARATION METHOD, 2014-2021, ($ MILLIONS)
2. GLOBAL METABOLOMICS MARKET ON THE BASIS OF IONIZATION METHOD, 2014-2021, ($ MILLIONS)
3. GLOBAL METABOLOMICS MARKET ON THE BASIS OF DETECTION METHOD, 2014-2021, ($ MILLIONS)
4. GLOBAL METABOLOMICS MARKET ON THE BASIS OF STATISTICAL METHODS, 2014-2021, ($ MILLIONS)
5. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN AGRICULTURE, 2014-2021, ($ MILLIONS)
6. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN BIO MAKER DISCOVER, 2014-2021, ($ MILLIONS)
7. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN PERSONALIZED MEDICINE, 2014-2021, ($ MILLIONS)
8. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN TOXICOLOGY, 2014-2021, ($ MILLIONS)
9. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN FUNCTIONAL GENOMICS, 2014-2021, ($ MILLIONS)
10. GLOBAL METABOLOMICS MARKET ON THE BASIS OF USE IN NUTRIGENOMICS, 2014-2021, ($ MILLIONS)
11. U.S METABOLOMICS MARKET, 2014-2021, ($MILLIONS)
12. CANADA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
13. U.K METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
14. GERMANY METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
15. FRANCE METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
16. SPAIN METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
17. ITALY METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
18. CHINA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
19. INDIA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
20. KOREA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
21. JAPAN METABOLOMICS MARKET, 2014 -2021, ($MILLIONS)
22. AUSTRALIA METABOLOMICS MARKET, 2014 -2021, ($MILLIONS
